Skip to main content

Search form

Click "Menu" to toggle open, click "Menu" again to close

Eyal Oren PhD, MS

Eyal  Oren PhD, MS

Assistant Professor

Epidemiology and Biostatistics Division

1295 N. Martin
Campus PO Box: 245210
Drachman Hall A218
Tucson, AZ 85724
(520) 626-7008
eoren@email.arizona.edu

Biography

Eyal Oren, PhD, MS, is an epidemiologist interested in infectious disease, with an emphasis on respiratory infections.  I am particularly interested in multidisciplinary, collaborative work that is innovative and emphasizes new tools and technologies. Methodologically, I am interested in the intersection between social and spatial epidemiologic methods, and their application to health disparities.  With a background in both academic and public health practice, I am excited about forging new ties between community and government health agencies and academia.

 

Education

2010                 Ph.D., Epidemiology, University of Washington

2004                 M.S., Epidemiology (Certificate in International Health), University of Washington

1998                 B.A., Neurobiology & Behavior (Concentration in Cognitive Science), Cornell University

 

Teaching

EPID 671          Social Epidemiology

CPH  459          Principles of Infectious Diseases Epidemiology

 

Research Interests

Most recently, my work has explored the ties between the environment, social factors and tuberculosis. I have also been interested in the use of molecular methods and emerging technologies to examine transmission of disease. My focus has primarily been focused on urban and immigrant populations, both in the US, on the border, and globally, in Vietnam, Mexico and Tanzania. In my previous life in government, I conducted epidemiologic investigations to support disease control and outbreak management; and evaluated the effectiveness of disease surveillance activities.
Research Group Homepage: http://oren.faculty.arizona.edu

 

Expertise

  • Infectious disease epidemiology
  • Tuberculosis (both active disease and latent infection)
  • Molecular epidemiology
  • Epidemiology in public health practice
  • Surveillance systems
  • Assessment of new technologies
  • Social epidemiology and health disparities
  • Global  and border health
  • Program evaluation, Monitoring & Evaluation

Current project areas

  1. Feasibility of latent tuberculosis screening among migrant farmworkers
  2. New technologies for latent tuberculosis infection
  3. Climate change and respiratory health
  4. Helicobacter pylori in Arizona
  5. Handwashing and microbial populations in the context of respiratory disease

Selected Publications

  1. Campo M, Shrestha A, Oren E, Thiede H, Duchin J, Narita M, Crothers K. Characterization of hepatitis C infection in tuberculosis patients in an urban city in the USA. Epidemiol Infect, 2013; 25:1-8.
  2. Oren E, Narita M, Nolan C, Mayer J. The role of area-level socioeconomic disadvantage on severe pulmonary tuberculosis. Public Health Reports, 2013; 128(2):99-109.
  3. Lindquist S, Ghosh-Chatterjee S, Field K, Allen S, Narita M, Oren E. Public Health Prioritization of TB Genotype Clusters. Emerging Infectious Diseases, 2013. 19(3): 493-6.
  4. Horne D, Campo M, Arentz M, Oren E, Crothers K, Narita M. Association between Smoking and Latent Tuberculosis in the U.S. Population. PLOS One, 2012;7(11):e49050.
  5. Oren E, Koepsell T, Leroux B, Mayer J. Area-based Socioeconomic Disadvantage and Tuberculosis Incidence. International Journal of the Union against TB and Lung Disease, 2012; 16(7):880-5.
  6. Barry PM, Shaw T, Oren E, Field K, Funk E, Langer AJ, Gardner TJ. Multistate Outbreak of Multidrug-Resistant Tuberculosis Identified by Genotype Cluster Investigation among Foreign-Born Seafood Production Workers. Emerging Infectious Diseases, 2012; 18(1): 113-116.
  7. Oren E, Winston CA, Pratt R, Robison VA, Narita M. Epidemiology of Urban Tuberculosis in the United States, 2000-2007. American Journal of Public Health. 2011; 101:1256-1263.
  8. Horne D, Oren E, Spitters CE, Johnson C, Narita M. How Soon can Smear Positive Tuberculosis Patients be Released from Inpatient Isolation? Infection Control and Hospital Epidemiology. 2010; 31(1): 78-84.
  9. Parimon T, Spitters CE, Muangman N, Euathrongchit J, Oren E, Narita M. Unexpected Pulmonary Involvement in Extrapulmonary Tuberculosis Patients. Chest. 2008; 134(3): 589-594.
  10. 10.   Ashworth M,  Horan KL, Freeman R, OrenE, NaritaM, Cangelosi GA. Use of PCR-based Mycobacterium tuberculosis Genotyping to Prioritize Tuberculosis Outbreak Control Activities. Journal of Clinical Microbiology. 2008; 46(3):856-862. 
  11. Oeltmann JE, Oren E,Haddad MB, Lake LK, Harrington T, Ijaz K, Narita M. Tuberculosis Outbreak in Marijuana Users, Seattle, Washington, 2004. Emerging Infectious Diseases. 2006; 12(7):1156-1159.
  12. Oren E, Smith NL, Doggen CJ, Heckbert SR, Lematire RN. Body mass index and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost. 2006 Oct;4(10):2273-5
  13. Freeman R, Kato-Maeda M, Hauge KA, Oren E, Narita M, Wallis CK, Nolan C, Small PM, Cangelosi GA. Use of Rapid Genomic Deletion Typing to Monitor a Tuberculosis Outbreak within an Urban Homeless Population. Journal of Clinical Microbiology. 2005; 43(11):5550-5554.
  14. Phillips KA, Stotland NE, Liang SY, Spetz J, Haas JS, Oren E. Out-of-pocket Expenditures for Oral Contraceptives and Number of Pill Packs Obtained per Purchase. Journal of the American Women’s Medical Association. 2004;59(1):36-42.
  15. Oren E, Shaffer ER and Guglielmo BJ. Impact of Emerging Technologies Upon Medication Errors and Adverse Drug Events: A Review of the Evidence. American Journal of Health-System Pharmacists 2003; 60:1447-1458.
  16. Oren E, Griffiths LP and Guglielmo BJ. Demographics of Antimicrobial Overrides Associated with Automated Dispensing Machines. American Journal of Health-System Pharmacists 2002; 59 (15): 1445-1448.
  17. Oren E, McCart G, Phillips KA. Evaluating the Potential Impact of Pharmacogenomics on ADRs: A Subject Review. Journal of Managed Care Pharmacy 2002; 8 (4): 285-290.
  18. Phillips KA, Veenstra DL, Oren E, Lee JK and Sadee WS. The Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions: A Systematic Review. JAMA 2001; 286 (18): 2270-2279.

 

Involvement in my research

  • If you are a student interested in my research, or other training opportunities, please email me
  • If you are interested in Epidemiology at MEZCOPH, go here

Research interests: - Infectious Disease Epidemiology - TB - Spatial epidemiology - Social Epidemiology

Curriculum Vitae: 

The University of Arizona